Food and beverage companies are responding to the rise of GLP-1 weight-loss medications with four distinct strategies: reformulating existing products for higher protein and fiber, launching entirely new brands built around weight management, shrinking portion sizes, and pursuing partnerships and marketing aimed at wellness-focused consumers. The shift is not speculative. Aon reports that households adopting these medications have cut grocery spending by 5.3%, fast food and coffee-chain spending by 8%, savory snack spending by 10.1%, and alcohol spending by up to 40%—and major brands from Nestlé to WeightWatchers are already moving to meet the changed appetite.
The GLP-1 Impact: A New Era for Food Consumption
GLP-1 receptor agonists were first approved in the United States in 2005 for diabetes and in 2014 for weight loss, but their cultural footprint expanded dramatically after semaglutide received approval for weight management in 2021, as physician Caitlin Dunne noted in the British Columbia Medical Journal. As people eat less junk food, major packaged-food companies are seeing the impact on sales and pivoting in an attempt to maintain consumer appetites. FTI Consulting frames the stakes plainly: these medications are not just the new diet fad but a remarkable change in dietary choices that could set the course for food retail and food service for years, and companies that proactively adapt their portfolios and communication strategies will be poised to thrive while those that do not face risk.
Consumer Behavior Shifts: From Quantity to Quality
The underlying driver is appetite suppression. A Cornell study cited by Grocery Dive found grocery spending shrank by 6% in households with at least one person taking weight-loss drugs, and industry reporting puts the reduction in daily calorie consumption among users at roughly 20–30%. "The billion-dollar question is: How do I make someone who is not hungry eat again?" asked Bruno Didier, head of B2B at meal-delivery service CookUnity, speaking on a panel at the IFT FIRST conference in Chicago.
The answer emerging from purchasing data is a shift in composition, not just volume: consumers are buying different products, eating smaller portions, and placing greater emphasis on protein, fiber, and nutrient density, according to Ingredient Exchange's industry analysis. Aon adds that fresh foods and dairy may see a slight increase in preference, while packaged-goods companies focused on alcohol and ultra-processed foods are likely to be most affected.
Strategy 1: Reformulation for Enhanced Nutrition
The most widespread response is adjusting existing product lines to cater to a more health-conscious consumer base. Aon observes that several leading brands are already promoting vitamins and protein-rich foods to support those using GLP-1s, alongside introducing healthier options and investing in updated marketing. Ingredient Exchange's analysis points in the same direction: protein-forward products, functional ingredients, and nutrient-dense formulations are becoming increasingly important across grocery stores, restaurants, and food manufacturing, and companies that adapt both product portfolios and ingredient sourcing strategies will be better positioned to meet changing demand. The logic is straightforward—when total calorie intake falls, every calorie has to work harder, so satiety and nutritional value become the primary purchase criteria.
Strategy 2: New Product and Brand Development
Beyond tweaking recipes, some companies are building entirely new offerings. In 2024, a leading consumer packaged goods company launched its first major U.S. brand in nearly three decades for consumers focused on weight management, with other food and beverage companies following suit, Aon reports. Nestlé has created new food products that cater to people who take weight-loss drugs, including its Vital Pursuit line of frozen meals, as reported by CNBC. J&J has moved in parallel with products like Luigi's mini pops—and if the new products succeed in grocery stores, J&J plans to take them to its foodservice customers as well. Notably, CNBC reports that J&J expects these products to appeal to a wider audience than just GLP-1 users, with health-conscious parents seen as a natural market, which spreads the commercial risk of the bet.
Strategy 3: Portion Size Reduction
Where reformulation changes what is in the package, portion reduction changes how much of it there is. Aon notes that some companies are marketing smaller portion sizes of existing product lines, a direct response to reduced caloric intake. The foodservice side faces the same pressure in a different form: Foodservice Footprint reports that research suggests people using GLP-1 medications eat smaller portions and fewer snacks, and argues that businesses may need to think strategically about catering to both normal and medically suppressed appetites—perhaps by offering a range of plate sizes or more sharing options. The analysis also flags a food-waste implication where users struggle to finish the same-sized portions as non-users, meaning portion strategy touches operations as well as marketing.
Strategy 4: Strategic Partnerships and Marketing
The fourth strategy moves beyond the product itself into positioning and ecosystem partnerships. Aon highlights that adapting to health demand involves investing in updated marketing strategies, and that GLP-1s have emerged as a key influence in M&A strategy, with acquisitions and divestitures driven by changing consumer demand. The clearest named example comes from reporting by CO- at the U.S. Chamber of Commerce: WW International, formerly Weight Watchers, launched a membership plan for members taking GLP-1 drugs—the WeightWatchers GLP-1 Program—pairing a food-adjacent brand directly with the medication experience. The pattern is to integrate food products into a broader wellness journey rather than sell them as standalone items, which is where communication strategy becomes as consequential as formulation.
Key Strategies for Food Businesses Adapting to GLP-1 Trends
The table below organizes the reported corporate actions into four distinct strategies, linking each to the consumer behavior that motivates it. Use it to distinguish defensive moves, such as shrinking portions to protect existing lines, from offensive ones, such as building new brands to capture the shift.
| Strategy | Consumer Driver | Reported Examples | Business Goal |
|---|---|---|---|
| Reformulation for Nutrition | Reduced appetite pushes users toward nutrient-dense foods, especially protein and fiber, as daily calories fall | Brands promoting vitamins and protein-rich foods for GLP-1 users; protein-forward, functional-ingredient formulations across grocery and restaurants | Keep existing product lines relevant by making every calorie nutritionally count |
| New Product/Brand Development | Users seek smaller, satisfying meals that support weight management; roughly 20–30% fewer daily calories consumed | Nestlé's Vital Pursuit frozen meals; J&J's Luigi's mini pops; a major CPG's first new U.S. brand in nearly three decades aimed at weight management | Capture the new demand directly, while appealing to a wider health-conscious audience |
| Portion Size Reduction | Appetite suppression means fewer calories and smaller portions, cutting grocery and fast-food spending | Smaller portion sizes of existing product lines; foodservice operators weighing varied plate sizes and sharing options | Align package and plate with reduced consumption and limit food waste |
| Strategic Partnerships & Marketing | GLP-1 use is part of a broader wellness journey, not just a diet | WeightWatchers GLP-1 Program membership; updated marketing strategies; GLP-1-influenced acquisitions and divestitures | Integrate products into wellness ecosystems and reposition portfolios for durable change |
Navigating the Future of Food
One caution tempers every strategy above: the behavior is still moving. CNBC reports that about 5% of users lapse in taking the medications due to cost, side effects, or hitting their weight goal, so demand built around GLP-1 users can fluctuate rather than ratchet permanently upward. That uncertainty is precisely why the four strategies differ in risk profile—portion reductions and reformulation defend existing revenue, while new brands and wellness partnerships bet on the trend deepening. FTI Consulting's assessment that pill versions of the medications are on the horizon suggests the shift is expected to accelerate, not plateau.
Adapting to a Changing Palate: The Future of Food
Food businesses must continuously monitor and adapt their product portfolios and marketing strategies to align with the evolving dietary preferences and reduced consumption patterns of GLP-1 users. The measurable indicator to watch is changes in product launches (e.g., new protein-focused lines, smaller portions), ingredient demand (e.g., fiber, plant proteins), and marketing collaborations with wellness platforms. Readers tracking this market should treat those three signals—launches, ingredient sourcing, and partnerships—as the concrete evidence of whether a company is genuinely adapting or merely watching, and should expect the next wave of announcements to follow the pattern already set by Nestlé, J&J, and WeightWatchers.
Sources
- How GLP-1s are Reshaping Food Buying Behavior — Aon
- Will Big Food outsmart GLP-1s? — British Columbia Medical Journal
- Food Business Strategies in the Weight Loss Drug Era — Fticonsulting
- Grocerydive
- How are GLP-1s Affecting the Food Industry? — Ingredient Exchange
- GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up — CNBC
- How will weight loss drugs impact foodservice? - Foodservice Footprint
